CASSADIE FARNSWORTH: Open Payments
NPI 1083307581 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 26 payments from 6 companies in 2025. Trend: 2023 $631 · 2024 $430 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $147 |
| Lundbeck LLC | 1 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, Auvelity, REXULTI, Xelstrym, INGREZZA.
Industry payments across OK — which companies pay providers there.
